Aurobindo Pharma

OverviewSuggest Edit

Aurobindo Pharma, a pharmaceutical company, manufactures and sells generic medicines to public and private health sectors in South Africa. The company’s product portfolio includes central nervous system, cardiovascular, pain, respiratory, anti-retroviral (for state tenders), metabolic, and anti-infective products. It markets and sells its products to health care professionals.
A well integrated pharma company, Aurobindo Pharma features among the top 10 companies in India in terms of consolidated revenues. Aurobindo exports to over 125 countries across the globe with more than 70% of its revenues derived out of international operations. Our customers include premium multi-national companies.. With multiple facilities approved by leading regulatory agencies such as USFDA, EU GMP, UK MHRA, South Africa-MCC, Health Canada and Brazil ANVISA, Aurobindo makes use of in-house R&D for rapid filing of patents, Drug Master Files (DMFs), Abbreviated New Drug Applications (ANDAs) and formulation dossiers across the world. Aurobindo Pharma is among the largest filers of DMFs and ANDAs from India.

TypePublic
Founded1986
HQHyderabad, IN
Websiteaurobindo.com
Employee Ratings3.6

Latest Updates

Employees (est.) (Sept 2020)18,469(+4%)
Revenue (FY, 2021)₹245.6 B(+9%)
Share Price (May 2022)₹562.5(-1%)
Cybersecurity ratingDMore
Discover new suppliers and conduct deeper comparison analysis with Craft for EnterpriseLearn more
Banner background

Key People/Management at Aurobindo Pharma

M. Sivakumaran

M. Sivakumaran

Whole Time Director
K. Ragunathan

K. Ragunathan

Independent Director & Non-Executive Chairman
M. Madan Mohan Reddy

M. Madan Mohan Reddy

Whole Time Director
M. Sitarama Murthy

M. Sitarama Murthy

Independent Director
Avnit Bimal Singh

Avnit Bimal Singh

Independent Director
Savita Mahajan

Savita Mahajan

Independent Director
Show more

Aurobindo Pharma Office Locations

Aurobindo Pharma has offices in Hyderabad and South Brunswick Township
Hyderabad, IN (HQ)
Hitech City Rd
Hyderabad, IN
Maitri Vihar Commercial Complex
South Brunswick Township, NJ, US
6 Wheeling Rd, Dayton
Show all (3)

Aurobindo Pharma Financials and Metrics

Aurobindo Pharma Revenue

Aurobindo Pharma's revenue was reported to be ₹245.58 b in FY, 2021
INR

Revenue (Q3, 2022)

59.9b

Gross profit (Q3, 2022)

33.0b

Net income (Q3, 2022)

6.0b

EBITDA (Q3, 2022)

10.5b

EBIT (Q3, 2022)

7.9b

Market capitalization (13-May-2022)

329.6b

Closing stock price (13-May-2022)

562.5

EV

329.6b
Aurobindo Pharma's current market capitalization is ₹329.6 b.
Annual
INRFY, 2018FY, 2019FY, 2020FY, 2021

Revenue

162.0b192.3b227.4b245.6b

Cost of goods sold

(71.5b)(92.6b)(102.4b)(105.3b)

Gross profit

93.9b103.9b129.1b144.8b

R&D expense

(6.7b)(8.7b)(7.4b)
Quarterly
INRQ1, 2019Q2, 2019Q3, 2019Q1, 2020Q2, 2020Q3, 2020Q1, 2021Q2, 2021Q3, 2021Q1, 2022Q2, 2022Q3, 2022

Revenue

41.8b46.7b51.8b53.6b55.2b58.0b58.4b63.8b63.5b56.9b58.9b59.9b

Cost of goods sold

(19.1b)(20.4b)(23.9b)(23.0b)(23.7b)(25.6b)(24.1b)(25.2b)(25.7b)(23.7b)(25.1b)(27.4b)

Gross profit

23.9b27.3b28.9b31.6b32.5b33.5b36.1b40.1b38.7b34.2b35.3b33.0b
Annual
INRFY, 2018FY, 2019FY, 2020FY, 2021

Cash

12.6b19.6b28.4b54.7b

Accounts Receivable

30.8b34.1b43.2b35.0b

Prepaid Expenses

3.2b2.3b5.9b4.1b

Inventories

58.6b72.5b77.0b90.3b
Quarterly
INRQ1, 2019Q2, 2019Q3, 2019Q1, 2020Q2, 2020Q3, 2020Q1, 2021Q2, 2021Q3, 2021Q1, 2022Q2, 2022Q3, 2022

Cash

17.8b21.3b34.8b45.0b

Accounts Receivable

32.0b41.6b38.1b39.3b

Prepaid Expenses

204.8m1.8b

Inventories

68.2b75.9b88.2b84.7b
Annual
INRFY, 2018FY, 2019FY, 2020FY, 2021

Net Income

32.4b30.9b37.4b73.4b

Depreciation and Amortization

5.6b6.7b8.7b9.4b

Inventories

(14.1b)(8.9b)(5.3b)(15.9b)

Accounts Payable

4.0b(5.0b)3.0b1.3b
Quarterly
INRQ1, 2019Q2, 2019Q3, 2019Q1, 2020Q2, 2020Q3, 2020Q1, 2021Q2, 2021Q3, 2021Q1, 2022Q2, 2022Q3, 2022

Net Income

17.3b22.8b19.9b

Depreciation and Amortization

4.8b5.1b5.7b

Inventories

(3.5b)(11.4b)6.1b

Accounts Payable

2.6b3.3b(5.6b)
INRFY, 2018

Revenue/Employee

11.6m
Show all financial metrics

Aurobindo Pharma Acquisitions / Subsidiaries

Company NameDateDeal Size
SandozSeptember 07, 2018$900 m

Aurobindo Pharma Revenue Breakdown

Embed Graph

Aurobindo Pharma revenue breakdown by business segment: 100.0% from MANUFACTURING GENERIC PHARMACEUTICALS AND ACTIVE PHARMACEUTICAL INGREDIENTS

Aurobindo Pharma Cybersecurity Score

Cybersecurity ratingPremium dataset

D

64/100

SecurityScorecard logo

Aurobindo Pharma Environment, Social & Governance (ESG) Ratings

CSRHub ESG ratingPremium dataset

40-49

out of 100

CSRHub logo

Aurobindo Pharma Online and Social Media Presence

Embed Graph

Aurobindo Pharma News and Updates

SBI, Infosys, Aurobindo Pharma And More - Top Stock Picks For May: KRChoksey

SBI, Infosys, Aurobindo Pharma And More - Top Stock Picks For May: KRChoksey

Aurobindo Pharma Acquires Veritaz's Formulations Business For Rs 171 Crore

This acquisition vehicle will greatly help Aurobindo as a launch pad for marketing biosimilar and other products in India.

Aurobindo Pharma Shares Gain On Cronus Deal Termination

Aurobindo Pharma terminated a deal to acquire a 51% stake in Cronus Pharma.

Aurobindo Pharma - Details On 483 Issued By U.S. FDA Towards Unit-I: Prabhudas Lilladher

Aurobindo Pharma - Details On 483 Issued By U.S. FDA Towards Unit-I: Prabhudas Lilladher

Aurobindo Pharma Q1 Review - Pricing Pressure Drags Profitability: Motilal Oswal

Aurobindo Pharma Q1 Review - Pricing Pressure Drags Profitability: Motilal Oswal

Aurobindo Pharma Q1 Results: Profit Falls Missing Estimates As U.S. Revenue Contracts

Aurobindo Pharma's Q1 profit misses estimates as its U.S. formulations revenue contracts.
Show more

Aurobindo Pharma Frequently Asked Questions

  • When was Aurobindo Pharma founded?

    Aurobindo Pharma was founded in 1986.

  • Who are Aurobindo Pharma key executives?

    Aurobindo Pharma's key executives are M. Sivakumaran, K. Ragunathan and M. Madan Mohan Reddy.

  • How many employees does Aurobindo Pharma have?

    Aurobindo Pharma has 18,469 employees.

  • What is Aurobindo Pharma revenue?

    Latest Aurobindo Pharma annual revenue is ₹245.6 b.

  • What is Aurobindo Pharma revenue per employee?

    Latest Aurobindo Pharma revenue per employee is ₹13.3 m.

  • Who are Aurobindo Pharma competitors?

    Competitors of Aurobindo Pharma include Siegfried Holding, Laboratorios Bago and Libbs Farmaceutica.

  • Where is Aurobindo Pharma headquarters?

    Aurobindo Pharma headquarters is located at Hitech City Rd, Hyderabad.

  • Where are Aurobindo Pharma offices?

    Aurobindo Pharma has offices in Hyderabad and South Brunswick Township.

  • How many offices does Aurobindo Pharma have?

    Aurobindo Pharma has 3 offices.